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INTRODUCTION
Methicillin-resistant staphylococci have become a major
pathogen of nosocomial infections (1-3). According to the
1996 national nosocomial infection surveillance in Korea,
Staphylococcus aureus (17.2%) was the most commonly isolated
organism, and 78.8% of S. aureus were methicillin-resistant
(4). Since the phenotypic expression of methicillin-resistance
is influenced by many factors-such as inoculum size, incuba-
tion time and temperature, pH of the medium, salt concen-
tration of the medium, and exposure to  -lactam antibiotics,
the performance of susceptibility tests has been erratic (5, 6).
Moreover, methicillin-resistant staphylococci are also resistant
to other antibiotics, including  -lactams, aminoglycosides,
and macrolides (7). Considering the importance of antibiotic
resistance in treatment, more rapid and reliable diagnostic me-
thods that can determine their resistance profiles are required.
Methicillin-resistance in S. aureus and coagulase negative
staphylococci (CNS) is primarily mediated by the overproduc-
tion of penicillin-binding protein (PBP) 2a, an altered PBP
with extremely low affinities for  -lactam antibiotics (8). The
mecA gene encoding PBP 2a, has very high levels of homol-
ogy in methicillin-resistant S. aureus (MRSA) and MRCNS,
and unlike PBP 2a, can be detected independently of growth
conditions (9). The mecA gene is therefore considered a useful
molecular marker of methicillin-resistance in all staphylococci.
The main mechanism of aminoglycoside resistance is drug
inactivation by plasmid- or transposon-mediated aminogly-
coside modifying enzymes (AME). The bifunctional enzyme
AAC(6′ )/APH(2′ ′ ) encoded by the aac(6′ )/aph(2′ ′ ) gene is the
most frequently encountered AME in staphylococcal isolates.
Additional enzymes, such as APH(3′ )-III encoded by aph(3′ )-
IIIa gene and the ANT(4′ )-I by ant(4′ )-Ia gene, are also found
in Staphylococcus species (10, 11).
Investigators have tried different approaches to detect these
resistance genes. In particular, polymerase chain reaction (PCR)
appears to be the more rapid, sensitive, and specific assay for
such detection than southern blot hybridization, macrorestric-
tion, fingerprinting, and determining the minimal inhibito-
ry concentration (MIC) of methicillin or oxacillin (12-14). In
particular, multiplex PCR that detects several genes simulta-
neously in the same PCR tube, has the advantage of identi-
fying genotypic resistance for several antibiotics more rapidly
and reliably (5, 15). The aims of the present study were: (i)
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Multiplex PCR for the Detection of Genes Encoding Aminoglycoside
Modifying Enzymes and Methicillin Resistance among Staphylococcus
Species
We developed multiplex polymerase chain reaction (PCR) to detect aac(6′ )/aph(2′ ′ ),
aph(3′ )-IIIa, and ant(4′ )-Ia, the genes encoding the most clinically relevant amino-
glycoside modifying enzymes (AME), and simultaneously, the methicillin resistant
gene, mecA, in Staphylococcus species. Clinical isolates of 45 S. aureus and 47 coag-
ulase negative staphylococci (CNS) from tertiary university hospitals were tested by
conventional susceptibility testing, using the agar dilution method and by multiplex
PCR. Of a total of 92 isolates, 61 isolates were found to be methicillin-resistant. Of
these, 54 isolates (89%) were found to be harboring mecA. Seventy-five percent of
the 92 isolates demonstrated resistance to at least one of the aminoglycosides test-
ed. Moreover, resistance to aminoglycosides was closely associated with methicillin-
resistance (p<0.05). The most prevalent AME gene was aac(6′ )/aph(2′ ′ ) which was
found in 65% of the isolates, and ant(4′ )-Ia and aph(3′ )-IIIa were present in 41% and
9% of the isolates, respectively. The concordance between methicillin-resistance
and the presence of mecA gene was 98% in S. aureus and 81% in CNS. The con-
cordance between gentamicin resistance and the presence of aac(6′ )/aph(2′ ′ ) gene
was 100% in S. aureus and 85% in CNS. The multiplex PCR method that we devel-
oped appears to be both a more rapid and reliable than conventional method.
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to develop a rapid multiplex PCR assay for the simultaneous
detection of genes encoding AME and PBP 2a; (ii) to compare
this multiplex PCR assay with standard microbiological meth-
ods of susceptibility testing; and (iii) to evaluate the preva-
lence of these resistance genes in Staphylococcus species.
MATERIALS AND METHODS
Bacterial Strains
Between June 2000 and August 2000, a total of 45 S. aureus
and 47 CNS from various sources (blood, sputum, urine, and
pus) were collected from 3 tertiary teaching hospitals located
in geographically different regions of Korea. Staphylococcal
strains were identified by using the MicroScan Pos Combo
Panel Type 6 (Baxter Diagnostics, West Sacramento, CA,
U.S.A.). The CNS were speciated by biochemical tests, using
API-Staph (bioMerieux, Marcy, L’ Etoile, France). They con-
sisted of S. epidermidis (29), S. haemolyticus (6), S. capitis (4), S.
chromogenes (3), S. lugdunensis (2), S. hominis (1), and S. warneri
(1), S. simulans (1). Stock cultures were stored frozen (-70℃)
in brain-heart infusion (BHI), containing 10% glycerol.
Susceptibility Testing and Determination of Minimal
Inhibitory Concentration (MIC)
Susceptibility tests for oxacillin, gentamicin, tobramycin,
kanamycin, and amikacin (Sigma, St. Louis, MO, U.S.A.) were
done by using the agar dilution method recommended by
the National Committee for Clinical Laboratory Standards
(16). Two  L of bacterial suspension, diluted to a final con-
centration of 107 CFU/mL (inoculum size of 2×104 CFU/
spot), were inoculated on Mueller-Hinton agar containing
each antibiotics from 0 to 512  g/mL. The inoculated plates
were then incubated at 37℃for 24 hr. The MIC was defined
as the lowest concentration of antibiotics that prevented visible
growth.
According to the current oxacillin breakpoint for methi-
cillin susceptibility, an oxacillin MIC breakpoint of ≤2 g/
mL was considered as methicillin susceptible in S. aureus
and ≤0.25  g/mL in CNS. Gentamicin and tobramycin
MICs of ≤4  g/mL, and kanamycin and amikacin MICs of
≤16  g/mL were considered to be susceptible to each
aminoglycoside. S. aureus ATCC 29213 and Escherichia coli
ATCC 25922 were used as standard strains. This testing
was performed two times to ensure accuracy.
DNA Purification from Culture Samples
Using a QIAamp DNA mini kit (QIAGEN, Hilden, Ger-
many), DNA was purified from staphylococcal isolates. A sin-
gle colony of the isolates was inoculated into brain heart infu-
sion broth (Becton Dickinson, Sparks, U.S.A.) and was incu-
bated for 24 hr at 37℃The bacterial pellet was then obtained
by centrifugation, resuspended in 200  L of lysis buffer (con-
taining 400  g of lysozyme) and incubated at 37℃for 1 hr.
The sample was then lysed by incubating at 56℃for 30 min
in the presence of 20  L of proteinase K (10 mg/mL) and
200  L of AL buffer. To extract the DNA, 200  L of 100%
ethanol was added and the lysate was transferred to a QIAamp
spin column, centrifuged at 8,000 rpm for 1 min, washed in
500  L of AW1 and AW2 buffer, and centrifuged to remove
all remaining AW1 and AW2 solution. The DNA was then
extracted according to the manufacturer’ s instructions.
Primers for PCR and Multiplex PCR
Using a PCR primer selection program (GeneFisher, Bioin-
formatics Bielefeld, Germany), four sets of primers specific for
aac(6′ )/aph(2′ ′ ), aph(3′ )-IIIa, ant(4′ )-Ia, and mecA gene were
designed from a site within the nucleotide sequence of the
published region of each resistance gene (Table 1).
DNA solution (2  L) as processed above was added to a PCR
mixture containing 0.2  M of the respective primers, 10  L
of a 10-fold concentrate of PCR buffer, 200  M of deoxynu-
cleoside triphosphates, and 0.5 U of Taq polymerase (Roche
Diagnostics, Mannheim, Germany). A Genecycler (Bio-Rad
laboratories, Hercules, CA, U.S.A.) was used for DNA ampli-
fication. After an initial denaturation (for 5 min at 95℃), 30
cycles of amplification were performed as follows: denaturation
at 95℃ for 2 min, annealing at 58℃ for 30 sec, and DNA
extension at 72℃for 30 sec. The reaction was achieved with
a final extension at 72℃for 7 min. Ten  L of the PCR prod-
ucts were then loaded onto a 2.5% agarose gel and electrophore-
sis was performed in Tris-borate-EDTA buffer containing
0.5  g of ethidium bromide per mL. Amplified ethidium
bromide-stained DNA fragments were then visualized on a
UV transilluminator at 300 nm.
S. aureus USS1504 (possessing mecA), S. aureus BM3002/
piP52 [possessing ant(4′ )-Ia], and Enterococcus faecalis BM6217
[possessing aph(3′ )-IIIa, aac (6′ )/aph(2′ ′ )] served as the posi-
tive controls for each resistance gene.
Statistic Analysis
Calculations were performed by using SPSS software ver-
Target genes Primer sequence Size
aac(6′ )/aph(2′ ′ ) 5′ -GAAGTACGCAGAAGAGA-3′ 491 bp
5′ -ACATGGCAAGCTCTAGGA-3′
aph(3′ )-IIIa 5′ -AAATACCGCTGCGTA-3′ 242 bp
5′ -CATACTCTTCCGAGCAA-3′
ant(4′ )-Ia 5′ -AATCGGTAGAAGCCCAA-3′ 135 bp
5′ -GCACCTGCCATTGCTA-3′
mecA 5′ -CCTAGTAAAGCTCCGGAA-3′ 314 bp
5′ -CTAGTCCATTCGGTCCA-3′
Table 1. Oligonucleotides used in this study
′sion 10.0. The correlation between methicillin-resistance and
aminoglycoside resistance was evaluated by using the  2 test
and Fisher’ s exact test. p<0.05 was considered statistically
significant. Comparisons of PCR assay results and the results
of conventional susceptibility testing were made by using a
matched 2-by-2 table.
RESULTS
Prevalence of Antimicrobial Resistance by Conven-
tional Methods
Of total 92 staphylococcal isolates, 61 (66%) isolates were
methicillin-resistant (S. aureus, 53%; CNS, 79%). Of these,
54 isolates (89%) were harboring mecA based on PCR analysis.
Overall, 66% of the isolates were resistant to gentamicin, 71%
to kanamycin, 71% to tobramycin, and 23% to amikacin
(Table 2). Sixty-nine (75%) staphylococcal isolates demonstrat-
ed resistance to at least one of the aminoglycosides tested. Of
the S. aureus, the proportion of MRSA that showed resistance
to the aminoglycosides was 4 times higher than that of the me-
thicillin susceptible S. aureus (MSSA; odd ratio, 95% CI, 2.03-
7.93; p<0.05). Of the CNS, the percentages of MRCNS show-
ing resistance to the aminoglycosides were 11.76 times higher
than methicillin susceptible CNS (MSCNS; odd ratio, 95%
CI, 4.36-33.46; p<0.05). Resistance to aminoglycosides was
closely associated with methicillin-resistance (p<0.05).
Distribution of Resistance Gene as Detected by Multi-
plex PCR
Amplified DNA fragments of four different sizes (135, 242,
314, and 491 bp) were detected on agarose gel electrophore-
sis (Fig. 1). Each amplified DNA fragment was consistently
observed in the positive control strains. No specific background
amplification products were encountered in this assay. There-
fore, the specificity of the primers selected for this study was
confirmed.
Of 92 staphylococcal isolates, 57 (62%) were mecA positive
(S. aureus, 55.6%; CNS, 68.1%, Table 3). aac(6′ )/aph(2′ ′ ) was
encountered most frequently (65%) and 50% of the isolates
carried this gene in combination with either ant(4′ )-Ia and/or
aph(3′ )-IIIa. The ant(4′ )-Ia and aph(3′ )-IIIa were present in
41% and 9%, respectively (Table 3). The most frequent com-
bination of genes was aac(6′ )/aph(2′ ′ ) with ant(4′ )-Ia (28%).
One isolate possessing the triple combination aac(6′ )/aph(2′ ′ ),
ant(4′ )-Ia, and aph(3′ )-IIIa was highly resistant to gentamicin
(MIC, 256  g/mL), kanamycin (>256  g/mL), tobramycin
(>256  g/mL), and amikacin (128  g/mL). Seventeen isolates
that were not detected to have any AME genes were determined
to be susceptible to all aminoglycosides tested, except for 4
of these isolates that were intermediate to tobramycin (MIC,
8 g/mL).
Accuracy of Multiplex PCR
The correlation between methicillin-resistance (OXr) and
the presence of the mecA gene is summarized in Table 4. For
S. aureus, there were 24 strains of OXr/mecA+and 20 strains of
OXs/mecA- isolates. For CNS, there were 30 strains of OXr/
mecA+and 8 strains of OXr/mecA-isolates. As a result, the con-
cordance between phenotype and genotype of methicillin-resis-
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Species No. of 
isolates (%)
Gentamicin Tobramycin Kanamycin Amikacin
MSSA 21 (23) 11 (52) 11 (52) 13 (62) 1 (5)
MRSA 24 (26) 20 (83) 22 (92) 20 (83) 10 (42)
MSCNS 10 (11) 2 (20) 2 (20) 2 (20) 0 (0)
MRCNS 37 (40) 28 (76) 30 (81) 30 (81) 10 (27)
Total 92 (100) 61 (66) 65 (71) 65 (71) 21 (23)
Abbreviations: MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-
resistant S. aureus; MSCNS, methicillin-susceptible CNS; MRCNS, methi-
cillin-resistant CNS.
Table 2. The distribution of aminoglycoside resistance in S. aureus
and coagulase negative staphylococci in relation to methicillin
resistance
Resistance
genes
MSSA
n=21 (%)
MRSA
n=24 (%)
MSCNS
n=10 (%)
MRCNS
n=37 (%)
Total
n=92 (%)
aac(6′ )/aph(2′ ′ ) 11 (52) 20 (83) 4 (40) 25 (68) 60 (65)
aph(3′ )-IIIa 3 (14) 5 (21) 0 (0) 0 (0) 8 (9)
ant(4′ )-Ia 1 (5) 10 (42) 10 (100) 17 (46) 38 (41)
mecA 1 (5) 24 (100) 2 (20) 30 (81) 57 (62)
Abbreviations: MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-
resistant S. aureus; MSCNS, methicillin-susceptible CNS; MRCNS, methi-
cillin-resistant CNS.
Table 3. The distribution of genes encoding aminoglycoside
modifying enzymes as determined by multiplex PCR assay in
Staphylococcus species in relation to methicillin resistance
M 1 2 3 4 5 6 7 8 9 10 11 12
(491 bp)
(314 bp)
(242 bp)
(135 bp)
aac(6′ )/aph(2′ ′ )
mecA
aph(3′ )-IIIa
ant(4′ )-Ia
Fig. 1. Gel electrophoresis of DNA fragments amplified by multiplex
PCR from reference strains and clinical isolates of Staphylococcus
species. Lanes: M, 1,000 bp DNA ladder (Bio-Rad Laboratories,
Hercules, CA, USA); 1, Enterococcus faecalis BM6217 [possessing
aph(3′ )-IIIa and aac(6′ )/aph(2′ ′ )]; 2, S. aureus USS1504 (possess-
ing mecA); 3, S. aureus BM 3002/piP524 (possessing ant(4′ )-Ia);
4-8, S. aureus (OX 128, GM 256); (OX 0.25, GM 32); (OX >256, GM
0.25); (OX 16, GM 64); (OX 0.5, GM 128); 9-12, CNS (OX 0.125,
GM <0.125); (OX >256, GM 256); (OX <0.125, GM <0.125); (OX
8, GM 256) [The parenthesis indicates MIC ( g/mL) of gentamicin
(GM) and oxacillin (OX)].634 S.M. Choi, S.-H. Kim, H.-J. Kim, et al.
tance was 98% in S. aureus and 81% in CNS. This resulted in
a positive predictive value (PPV) of 95% and a negative pre-
dictive value (NPV) of 80% for the mecA assay.
The correlation between gentamicin resistance and the pres-
ence of aac(6′ )/aph(2′ ′ ) gene is summarized in Table 5. In S.
aureus, 100% concordance was observed. However, in CNS,
the concordance was 81%. The discrepancy was due to 7 strains
of CNS [3 GMs/aac(6′ )/aph(2′ ′ )+ and 4 GMr/aac(6′ )/aph(2′ ′ )-
isolates]. The aac(6′ )/aph(2′ ′ ) gene detection by multiplex
PCR had a PPV of 95% and a NPV of 88% for gentamicin
resistance.
The concordances between kanamycin, tobramycin, amikacin
resistance and the presence of aac(6′ )/aph(2′ ′ )gene were 91%,
96%, and 78%, respectively, in S. aureus (vs. 81%, 77%, and
51% in CNS).
DISCUSSION
Although culture-based methods are generally reliable for
detecting methicillin-resistant staphylococci, the detection of
mecA gene by PCR assay is now considered as the gold stan-
dard. In particular, multiplex PCR assay that simultaneously
detects several genes in a single reaction has the advantage of
identifying genotypic resistance for several antibiotics more
rapidly and reliably. Several studies have used multiplex PCR
for the detection of genes encoding methicillin-resistance and/
or genes for species identification in cases of staphylococcal
infection (11, 14, 17). We designed 4 sets of primers, which
were specific for aac(6′ )/aph(2′ ′ ), aph(3′ )-IIIa, and ant(4′ )-Ia,
the genes encoding the most clinically relevant AME, and mecA
gene. We successfully developed a rapid multiplex PCR me-
thod, which was performed in less than 6 hr. Moreover, the
accuracy of this method was reliable, compared with conven-
tional testing. Recently, the breakpoint for oxacillin resistance
in CNS was lowered from 2  g/mL to 0.25  g/mL (18). The
use of the recently determined oxacillin MIC interpretative
breakpoints resulted in decreased percentages of OXs/mecA+
CNS (19). As a result, we observed that the concordance be-
tween genotype and phenotype increased from 68% to 81%
in this study. However, 11% (10/92) of the strains were dis-
cordant, and most of these were CNS (7 strains of OXr/mecA-
and 2 strains of OXs/mecA+). In the case of OXr/mecA- strains,
non-PBP 2a-dependent mechanisms such as hyperproduction
of  -lactamase and alteration of PBP types may participate in
the expression of resistance (20, 21). We performed nitrocefin
disk test (Becton Dickinson, Sparks, U.S.A.) for the 5 strain
out of 7 discordant OXr/mecA- strain and 3 strain showed
positive results. And additional study to confirm the mech-
anism of oxacillin resistance will be needed. Two OXs/mecA+
strains were identified as S. hominis and S. capitis and the MIC
for these strains were 0.125  g/mL. The mecA gene is not con-
sistently expressed and certain auxiliary genes, such as femA,
mecR, and the gene encoding the  -lactamase plasmid may
participate in the control of its expression.
Aminoglycosides play an important role in serious staphy-
lococcal infections despite reports of increased resistance to
these drugs. Gentamicin and tobramycin are the most active
against staphylococci, and are often used in combination with
either a  -lactam or a glycopeptide, especially in the treatment
of staphylococcal endocarditis. Drug inactivation by AME is
the main mechanism of aminoglycoside resistance. The bifunc-
tional enzyme, AAC(6′ )/APH(2′ ′ ), encoded by the aac(6′ )/
aph(2′ ′ ) gene, is the most frequently encountered AME in
Species
No. of strains tested by
agar dilution with OX
PCR results for mecA
No. of + No. of -
S. aureus 24 (resistant) 24 0
21 (susceptible) 1 20
CNS 37 (resistant) 30 7
10 (susceptible) 2 8
Abbreviations: CNS, coagulase negative staphylococci; OX, oxacillin
resistance; +, positive; -, negative.
Table 4. Correlation between oxacillin resistance and the pres-
ence of the mecA gene
Species
No. of strains tested
by agar dilution
with GM
PCR results for
aac(6′ )/aph(2′ ′ )
No. of + No. of -
S. aureus 31 (resistant) 31 0
14 (susceptible) 0 14
CNS 30 (resistant) 26 4
17 (susceptible) 3 14
Abbreviations: CNS, coagulase negative staphylococci; GM, gentam-
icin resistance; +, positive; -, negative.
Table 5. Correlation between gentamicin resistance and the
presence of the aac(6′ )/aph(2′ ′ ) gene
  
Fig. 2. The incidence of genes encoding aminoglycoside modify-
ing enzymes, as determined by multiplex PCR in 92 isolates of
Staphylococcus species.
30 (33%)
3 (3%)
aph(3′ )-IIIa
aac(6′ )/aph(2′ ′ )
ant(4′ )-Ia
not detected:
17 (18%)
12 (13%)
1 (1%)
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staphylococcal isolates and mediates resistance to gentamicin,
tobramycin, dibekacin, netilmicin, amikacin, and isepamicin
(11). In the present study, the concordances between gentam-
icin, kanamycin, tobramycin, and amikacin resistance and the
presence of aac(6′ )/aph(2′ ′ ) gene were 100%, 91%, 96%, and
78%, respectively, in S. aureus (vs. 81%, 81%, 77%, and 51%
in CNS). In 4 GMr/aac(6′ )/aph(2′ ′ )- isolates of 7 discordant
CNS, other mechanisms, such as a loss of permeability and
ribosomal alteration, may mediate resistance. Three isolates
of GMs/aac(6′ )/aph(2′ ′ )+ CNS showed MICs of 0.25  g/mL,
2  g/mL, and 4  g/mL, respectively, and those were relatively
higher than the usual MIC of 0.015-0.125  g/mL in gentam-
icin susceptible S. epidermidis. This may be due to the partial
expression of aac(6′ )/aph(2′ ′ )gene (15).
An ANT(4′ ′ )-I enzyme encoded by ant(4′ )-Ia is known to
mediate resistance to neomycin, kanamycin, tobramycin and
amikacin in staphylococci and resistance to neomycin, and
kanamycin is conferred by an APH(3′ )-III enzyme encoded by
aph(3′ )-IIIa (11). However, the concordance between kana-
mycin resistance and the presence of aph(3′ )-IIIa, tobramycin
resistance and the presence of ant(4′ )-Ia, and amikacin resis-
tance and the presence of ant(4′ )-Ia, was less than 50% (data
was not shown). Ida et al. reported that ant(4′ )-Ia is the most
prevalent gene in MRSA, and the isolates possessing this gene
presented high level of resistance to tobramycin (22). In our
study, the concordance between tobramycin resistance and the
presence of ant(4′ )-Ia gene was only 45%. In addition, we found
no significant difference in the MICs of ant(4′ )-Ia positive and
negative isolates.
Several reports have stated that aminoglycoside resistance
is closely related to methicillin-resistance (10, 11, 23, 24). Our
study also shows a significant correlation between aminogly-
coside and methicillin-resistance. This is presumed to be due
to the adjacent locations of mecA gene and of the AME encod-
ing genes, and further study is needed on this topic (22). In
the clinical setting, such as in MRSA endocarditis, which re-
quires combination therapy with aminoglycosides, a more
prudent choice of aminoglycosides is required.
The mechanisms of aminoglycoside resistance have become
more complex with the increased usage of aminoglycosides
over time. Moreover, there is no rapid and reliable method for
detecting aminoglycoside resistance. To the best of our knowl-
edge, this is the first report about AME and its corresponding
genes, using multiplex PCR in Korea and the result of this
study reiterates the usefulness of DNA-based assays for the
detection of antibiotic resistance genes associated with staphy-
lococcal infections. However, for the application of this method
in the clinical practice, additional data for a large number of
clinical isolates will be needed. Also, the clinical result of the
antimicrobial therapy for the isolates according to the resistant
pattern should be evaluated. Considering the high prevalence
of aminoglycoside resistance, observed in this study, period-
ic surveillance of aminoglycoside resistance and of the corre-
sponding genes is needed. We believe that such PCR assays
allow for the faster establishment of effective antibiotic ther-
apies, and will lead to improved therapeutic success and re-
duced empirical treatments with broad-spectrum antibiotics,
which are costly and have high toxicities, and eventually slow
potential development of antibiotic resistant organisms. In
terms of infection control programs, such rapid detection of
resistance could be used to prevent nosocomial spread of MRSA
in advance. 
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